SIGA TECHNOLOGIES INC (SIGA) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does SIGA TECHNOLOGIES INC Do?
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York. SIGA TECHNOLOGIES INC (SIGA) is classified as a small-cap stock in the Healthcare sector, specifically within the Pharmaceutical Products industry. The company is led by CEO Phillip L. Gomez and employs approximately 40 people. With a market capitalization of $370M, SIGA is one of the notable companies in the Healthcare sector.
SIGA TECHNOLOGIES INC (SIGA) Stock Rating — Reduce (April 2026)
As of April 2026, SIGA TECHNOLOGIES INC receives a Reduce rating with a composite score of 43.5/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.SIGA ranks #2,643 out of 4,446 stocks in our coverage universe. Within the Healthcare sector, SIGA TECHNOLOGIES INC ranks #352 of 838 stocks, placing it in the upper half of its Healthcare peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
SIGA Stock Price and 52-Week Range
SIGA TECHNOLOGIES INC (SIGA) currently trades at $4.44. The stock gained $0.04 (0.9%) in the most recent trading session. The 52-week high for SIGA is $9.62, which means the stock is currently trading -53.8% from its annual peak. The 52-week low is $4.81, putting the stock -7.7% above its annual trough. Recent trading volume was 0 shares, suggesting relatively thin trading activity.
Is SIGA Overvalued or Undervalued? — Valuation Analysis
SIGA TECHNOLOGIES INC (SIGA) carries a value factor score of 65/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 10.80x, compared to the Healthcare sector average of 23.63x — a discount of 54%. The price-to-book ratio stands at 1.63x, versus the sector average of 2.75x. The price-to-sales ratio is 3.22x, compared to 1.66x for the average Healthcare stock. On an enterprise value basis, SIGA trades at 9.62x EV/EBITDA, versus 6.34x for the sector.
Overall, SIGA's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.
SIGA TECHNOLOGIES INC Profitability — ROE, Margins, and Quality Score
SIGA TECHNOLOGIES INC (SIGA) earns a quality factor score of 50/100, indicating solid business quality with consistent operational execution. The return on equity (ROE) is 15.1%, compared to the Healthcare sector average of -43.5%, which is within a healthy range. Return on assets (ROA) comes in at 13.7% versus the sector average of -33.1%.
On a margin basis, SIGA TECHNOLOGIES INC reports gross margins of 78.0%, compared to 71.5% for the sector. The operating margin is -90.1% (sector: -66.1%). Net profit margin stands at -47.9%, versus -58.7% for the average Healthcare stock. Revenue growth is running at -88.0% on a trailing basis, compared to 10.6% for the sector. The overall profitability profile is adequate, though there may be room for margin expansion.
SIGA Debt, Balance Sheet, and Financial Health
SIGA TECHNOLOGIES INC has a debt-to-equity ratio of 10.0%, compared to the Healthcare sector average of 32.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 11.83x, indicating strong short-term liquidity. Total debt on the balance sheet is $0. Cash and equivalents stand at $172M.
SIGA has a beta of 0.62, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for SIGA TECHNOLOGIES INC is 54/100, reflecting average volatility within the normal range for its sector.
SIGA TECHNOLOGIES INC Revenue and Earnings History — Quarterly Trend
In TTM 2026, SIGA TECHNOLOGIES INC reported revenue of $101M and earnings per share (EPS) of $0.33. Net income for the quarter was $30M. Gross margin was 78.0%. Operating income came in at $34M.
In FY 2025, SIGA TECHNOLOGIES INC reported revenue of $95M and earnings per share (EPS) of $0.33. Net income for the quarter was $23M. Gross margin was 68.6%. Revenue grew -31.8% year-over-year compared to FY 2024. Operating income came in at $24M.
In Q3 2025, SIGA TECHNOLOGIES INC reported revenue of $3M and earnings per share (EPS) of $-0.09. Net income for the quarter was $-6M. Gross margin was 61.8%. Revenue grew -73.8% year-over-year compared to Q3 2024. Operating income came in at $-10M.
In Q2 2025, SIGA TECHNOLOGIES INC reported revenue of $81M and earnings per share (EPS) of $0.50. Net income for the quarter was $35M. Gross margin was 68.5%. Revenue grew 271.9% year-over-year compared to Q2 2024. Operating income came in at $46M.
Over the past 8 quarters, SIGA TECHNOLOGIES INC has demonstrated a growth trajectory, with revenue expanding from $22M to $101M. Investors analyzing SIGA stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
SIGA Dividend Yield and Income Analysis
SIGA TECHNOLOGIES INC (SIGA) currently pays a dividend yield of 6.6%. At this yield, a $10,000 investment in SIGA stock would generate approximately $$656.00 in annual dividend income.
SIGA Momentum and Technical Analysis Profile
SIGA TECHNOLOGIES INC (SIGA) has a momentum factor score of 36/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 40/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 6/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.
SIGA vs Competitors — Healthcare Sector Ranking and Peer Comparison
Within the Healthcare sector, SIGA TECHNOLOGIES INC (SIGA) ranks #352 out of 838 stocks based on the Blank Capital composite score. This places SIGA in the upper half of all Healthcare stocks in our coverage universe. Key competitors and sector peers include ASTRAZENECA PLC (AZN) with a score of 61.4/100, Sol-Gel Technologies Ltd. (SLGL) with a score of 56.6/100, VIEMED HEALTHCARE, INC. (VMD) with a score of 53.4/100, Innoviva, Inc. (INVA) with a score of 52.7/100, and JOHNSON & JOHNSON (JNJ) with a score of 51.7/100.
Comparing SIGA against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full SIGA vs S&P 500 (SPY) comparison to assess how SIGA TECHNOLOGIES INC stacks up against the broader market across all factor dimensions.
SIGA Next Earnings Date
No upcoming earnings date has been announced for SIGA TECHNOLOGIES INC (SIGA) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy SIGA? — Investment Thesis Summary
The quantitative profile for SIGA TECHNOLOGIES INC suggests caution. The value score of 65/100 suggests attractive pricing relative to fundamentals. Momentum is weak at 36/100, a headwind for near-term performance.
In summary, SIGA TECHNOLOGIES INC (SIGA) earns a Reduce rating with a composite score of 43.5/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on SIGA stock.
Related Resources for SIGA Investors
Explore more research and tools: SIGA vs S&P 500 comparison, top Healthcare stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare SIGA head-to-head with peers: SIGA vs AZN, SIGA vs SLGL, SIGA vs VMD.